Methods for reducing the incidence of necrotizing enterocolitis

• US 6,080,787 A
• Filed: 10/03/1997
• Issued: 06/27/2000
• Est. Priority Date: 02/21/1997
• Status: Expired due to Term

• Current Assignee: Abbott Laboratories Incorporated
• Original Assignee: Abbott Laboratories Incorporated
• Inventors: Benson, John D., Dohnalek, Margaret H., Montalto, Michael B., Carlson, Susan E., Ponder, Debra L., Diodato, David V., Borror, David A.
• Primary Examiner(s): Spivack, Phyllis G.
• Application Number:
  US08/943,576
• Time in Patent Office: 998 Days
• Field of Search: 514/547, 514/560, 514/78
• US Class Current: 514/560
• CPC Class Codes: A61K 31/202 having three or more double bonds, e.g. linolenic eicosanoids, e.g. leukotrienes A61K31/557
• CPC Class Codes: A61P 1/04 for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Abstract

Enteral formulas that contain long-chain polyunsaturated fatty acids (PUFAs), as arachidonic acid (AA) and docosahexaenoic acid (DHA) that are essentially free of cholesterol, are described. More particularly, the invention relates to methods for reducing the incidence of necrotizing enterocolitis by administering compositions which provide ω-6 and ω-3 long chain PUFAs, phospholipids and/or choline. Compositions from egg yolk lipids are presently preferred as they contain ω-6 and ω-3 long chain PUFAs and are predominantly in a phosphtidylcholine form. This is believed to provide a synergistic effect.

Claims

1. A method for reducing the incidence of necrotizing enterocolitis in an infant, said method comprising administering to an infant which is susceptible to necrotizing enterocolitis an effective amount of a nutritional composition containing protein, carbohydrate and phospholipids to provide at least 1.0 mg of ω

-6 polyunsaturated fatty acids per kg per day.

2. The method according to claim 1 wherein said at least one ω

-6 polyunsaturated fatty acid includes arachidonic acid.

3. The method according to claim 2 wherein said administration is performed enterally.

4. The method according to claim 1 wherein said at least one ω

-6 polyunsaturated fatty acid is administered in combination with at least one ω

-3 polyunsaturated fatty acid.

5. The method according to claim 4 wherein said ω

-3 polyunsaturated fatty acid comprises docosahexaenoic acid.

6. The method according to claim 4 wherein said ω

-6 polyunsaturated fatty acid comprises arachidonic acid and said ω

-3 polyunsaturated fatty acid comprises docosahexaenoic acid.

7. The method according to claim 6 wherein said administration is performed by feeding a sufficient amount of an enteral composition containing arachidonic acid and docosahexaenoic acid to deliver to said infant about 1.0 to about 60 mg per kg per day of arachidonic acid and about 0.25 to about 35 mg per kg per day of docosahexaenoic acid.

8. The method according to claim 7 wherein the weight ratio of arachidonic acid to docosahexaenoic acid ranges from about 2 to about 4.

9. The method according to claim 7 wherein the enteral composition additionally comprises vitamins and minerals.

10. The method according to claim 4 wherein said ω

-6 polyunsaturated fatty acid and said ω

-3 polyunsaturated fatty acid are long chain fatty acids independently selected from one or more sources selected from the group consisting of egg lecithin, fungal oils, algal oils and marine oils.

11. The method according to claim 4 wherein said ω

-6 polyunsaturated fatty acid and said ω

-3 polyunsaturated fatty acid are derived from genetically modified oil-bearing plants.

12. The method according to claim 4 wherein said ω

-6 polyunsaturated fatty acid and said ω

-3 polyunsaturated fatty acid are in the form of phospholipids.

13. The method according to claim 1 comprising feeding to an infant which is susceptible to necrotizing enterocolitis a sufficient amount of an enteral formula containing:

protein, carbohydrate and phospholipids, said phospholipids providing arachidonic acid and docosahexaenoic acid in concentrations to deliver to said infant from about 5 to about 40 mg per kg per day of arachidonic acid and from about 1.5 to about 20 mg per kg per day of docosahexaenoic acid, wherein the weight ratio of arachidonic acid to docosahexaenoic acid ranges from about 2 to about 4.

14. A method for decreasing the incidence of necrotizing enterocolitis in an infant, said method comprising feeding to said infant a sufficient quantity of an enteral nutritional composition containing protein, carbohydrate and phospholipids to provide at least 2.0 mg of ω

-6 polyunsaturated fatty acids per kg per day.

15. The method according to claim 14 wherein said feeding further provides at least 0.5 mg ω

-3 polyunsaturated fatty acids per kg per day.

16. The method according to claim 15 wherein said feeding provides at least 2.0 mg arachidonic acid and at least 0.5 mg docosahexaenoic acid per kg per day.

17. The method according to claim 16 wherein said feeding provides from about 5 to about 40 mg arachidonic acid per kg day.

18. The method according to claim 17 wherein said enteral composition comprises egg phospholipid.

19. The method according to claim 15 wherein said enteral composition comprises egg phospholipid.

20. The method according to claim 19 wherein said enteral composition further comprises vitamins and minerals.

21. A method for decreasing the incidence of necrotizing enterocolitis in an infant, said method comprising administering to an infant susceptible to necrotizing enterocolitis a sufficient quantity of a nutritional composition containing protein, carbohydrates and phospholipids to provide between about 60 and about 2400 μ

moles of phospholipids per kg day.

22. The method of claim 21 comprising administering a sufficient quantity of said nutritional composition to provide between about 200 and about 1500 μ

moles of phospholipids per kg per day.

23. The method of claim 21 wherein said phospholipids are derived from egg lecithin.

24. The method of claim 21 wherein said phospholipids are administered in combination with one or more polyunsaturated fatty acids selected from the group consisting of arachidonic acid and docosahexaenoic acid.

25. The method of claim 24 wherein said phospholipids are administered in combination with arachidonic acid and docosahexaenoic acid to give from about 200 to about 1500 μ

moles of phospholipid;

from about 5.0 mg to about 40 mg arachidonic acid; and

from about 1.5 mg to about 20 mg docosahexaenoic acid per kg per day.

26. The method of claim 21 wherein said phospholipids are administered enterally.

27. A method for decreasing the incidence of necrotizing enterocolitis in an infant, said method comprising administering to an infant susceptible to necrotizing enterocolitis a sufficient quantity of a nutritional composition containing protein, carbohydrates and phospholipids to provide between about 60 and about 1800 μ

moles of choline per kg per day.

28. The method of claim 31 comprising administering a sufficient quantity of said nutritional composition to provide between about 150 and about 1200 μ

moles of choline per kg per day.

29. The method of claim 27 wherein said choline is in the form of phosphatidylcholine.

30. The method of claim 29 wherein said phosphatidylcholine is derived from egg lecithin.

31. The method of claim 27 wherein said choline is administered in combination with one or more polyunsaturated fatty acids selected from the group consisting of arachidonic acid and docosahexaenoic acid.

32. The method of claim 31 wherein said choline is administered in combination with arachidonic acid and docosahexaenoic acid to give from about 150 to about 1200 μ

moles of choline;

from about 5.0 mg to about 40 mg arachidonic acid; and

from about 1.5 mg to about 20 mg docosahexaenoic acid per kg per day.

33. The method of claim 27 wherein said choline is adminstered enterally.